Prostate Cancer Market

Table of Content

1. INTRODUCTION
   1. Study Assumptions and Market Definition
   2. Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
   1. Market Overview
   2. Market Drivers
      1. Rising Prevalence of Prostate CancerCases
   3. Market Restraints
      1. Limited Treatment Options
      2. Adverse Effects of Treatment
   4. Market Opportunities
      1. Development of Digital Health Solutions for Prostate Cancer Management
   5. Market Trends
      1. Increasing Adoption of Active Surveillance
      2. Advancements in Precision Medicine
5. MARKET SEGMENTATION
   1. By Drug Class
      1. Hormonal Therapy
      2. Chemotherapy
      3. Immunotherapy
      4. Targeted Therapy
   2. By End-Users
      1. Clinic
      2. Hospital
      3. Others
   3. By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Sales
      4. Others
   4. By Key Geographic Regions
      1. North America
         1. United States
         2. Canada
         3. Mexico
      2. Europe
         1. Germany
         2. United Kingdom
         3. France
         4. Italy
         5. Spain
         6. Rest of Europe
      3. Asia Pacific
         1. China
         2. Japan
         3. India
         4. Australia
         5. South Korea
         6. Rest of Asia Pacific
      4. Middle East and Africa
         1. GCC
         2. South Africa
         3. Rest of Middle East and Africa
      5. South America
         1. Brazil
         2. Argentina
         3. Rest of South America
6. COMPETITIVE LANDSCAPE
   1. Company Profile
      1. Abbott
      2. AbbVie Inc.
      3. AstraZeneca
      4. Astellas Pharma Inc.
      5. Bristol-Myers Squibb Company
      6. Bayer AG
      7. Dendreon Pharmaceuticals LLC.
      8. Ferring B.V.
      9. F. Hoffmann-La Roche Ltd.
      10. Genentech, Inc.
      11. GlaxoSmithKline plc
      12. Ipsen Pharma
      13. Johnson & Johnson Private Limited
      14. Myovant Sciences GmbH
      15. Novartis AG
      16. Sanofi
      17. Pfizer Inc.
      18. Teva Pharmaceutical Industries Ltd.
      19. Takeda Pharmaceutical Company Limited.
      20. Tolmar Pharmaceuticals, Inc.
7. MARKET OPPORTUNITIES AND FUTURE TRENDS

Frequently Asked Questions

Q.1. What is the projected market value of the global Prostate Cancermarket?

The global market of Prostate Cancer is projected to reach USD 24.7 Bn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global Prostate Cancermarket?

The global Prostate Cancer market has an estimated annual growth rate of 8.5% .

Q.3. What are the recent trends of Prostate Cancermarket?

Increasing adoption of active surveillance and advancements in precision medicine are someof the major trends of the market that is projected to boost the market growth in the near future.

Q.4. Which are the top companies to hold the market share in Prostate Cancer?

The major companies profiled in this report include Abbott, AbbVie Inc., AstraZeneca, Astellas Pharma Inc., Bristol-Myers Squibb Company, Bayer AG, Dendreon Pharmaceuticals LLC., Ferring B.V., F. Hoffmann-La Roche Ltd., Genentech, Inc., GlaxoSmithKline plc, Ipsen Pharma, Johnson & Johnson Private Limited, Myovant Sciences GmbH, Novartis AG, Sanofi, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited., Tolmar Pharmaceuticals, Inc., among others.

Q.5. Which region is estimated to held highest CAGR inProstate Cancermarket?

North America is estimated to hold biggest share in the market for Prostate Cancer.